The 10 largest medical device companies in the world

Mergers & acquisitions continue to change the medical device landscape, as reflected in Medical Design & Outsourcing’s new Big 100 list. We pulled financial regulatory filings and reached out to major companies in some cases to create a list of the 100 largest medical device companies in the world, ranked by annual revenue for their

Pages: 1 2 3 4 5 6 7 8 9 10 11

The 10 largest medtech employers – and what their workers really think

Among the 10 largest medtech employers, workers feel pride in working on life-saving products – but there’s also frustration with big corporate bureaucracy. That was the major takeaway as Medical Design & Outsourcing compiled some of the most insightful current and former employee reviews posted on Glassdoor. The 10 companies we’re counting down were the

Pages: 1 2 3 4 5 6 7 8 9 10 11

Stryker launches new deformity correction hardware

Stryker’s Foot and Ankle business unit announced that it is launching its Hoffman LRF Hexapod hardware and online application for deformity correction. The Hoffmann LFR Hexapod uses mathematical algorithms to calculate solutions to correct deformities. “Stryker’s Hoffman LRF Hexapod and its innovative software is a step forward for surgeons and patients involved with complex deformity

3 enduring leadership lessons to boost your medtech success

This one is for the caffeine-addled world-changers out there, who consume leadership memes on Linkedin for breakfast, searching for inspiration with the same passion as a bigfoot truther. Brian Johnson, Publisher For the past 6 years, I’ve interviewed the most successful men and women in the medical device industry at DeviceTalks, a conference I founded

Pages: 1 2 3 4

Medtech stories we missed this week: March 17, 2017

The FDA awarded 510(k) clearance to a couple of medtech companies this week while others received tax breaks and incentives, including a local tax break for a $154 million Stryker R&D facility planned in Michigan. Here are some medtech stories we missed this week but thought were worth mentioning. 1. FirstRay wins FDA 510(k) clearance

9 women medtech leaders you need to know

  Women account for 50.8% of the U.S. population, yet they only represent 14.8%  of all CEOs in the U.S., according to the Center for American Progress. About 78.4% of healthcare industry workers – but only 34.3% of all surgeons and physicians and 15.9% of medical school deans – are women, the center reports. And

Pages: 1 2 3 4 5 6 7 8 9 10

11 surgical robotics companies you need to know

Fink Densford, Associate Editor Robotic surgery is taking off, and the field is becoming increasingly diverse. We’ve collected information on the biggest players in the field so far. Intuitive Surgical’s da Vinci robot remains the premier surgical robotics company, with other companies including Stryker and Zimmer-Biomet only getting into the field in recent years. Read on

Pages: 1 2 3 4 5 6 7 8 9 10 11 12

Stryker Q4 earnings take hit from recalled hip implants

Stryker’s profits decreased 2.3% year-over-year in the fourth quarter, to $510 million, amid charges related to its recalled Rejuvenate or ABG II modular metal-on-metal neck hip stems, as well as expenses related to restructuring and acquisition costs. Earnings per share were $1.34, down 2.9%. Excluding the charges, Stryker’s profits would have been up 14.1% to $1.78

Surgical equipment market to double to more than $20 billion

The global surgical equipment market is poised to reach a value of $20.3 billion by 2025, according to a report from Grand View Research. The worldwide market for surgical equipment was $9.9 billion in 2015 and is expected to grow at a CAGR of 7.6% over the next seven years. The study says the rise of minimally invasive procedures is

Device Talks: The leadership lessons of John Brown, the man who built Stryker

For a man who took a company from $17 million in sales to a $4.5 billion publicly traded juggernaut listed at #307 on Forbes 400 billionaires, John Brown is a remarkably humble man. He’s also, for all intents and purposes, the man who put Stryker on the map during his 32-year tenure as CEO, which

Stryker enrolls the 1,000th patient into the Trevo Retriever Registry

Stryker announced enrollment of the 1,000th patient into its Trevo Retriever Registry. Data from the first 500 patients with 90-day follow-up completed showed that 9 out of 10 patients had complete or near complete removal of the clot and over half were functionally independent. These real-world results validate the benefit of clot retrieval with the

Stryker’s Signature Portfolio drill line to debut at AANS conference

Stryker’s Instruments group announces full availability of its most comprehensive and customizable high-speed drill line, the Signature Portfolio. The lineup of Signature Portfolio components will be on display at the American Association of Neurological Surgeons (AANS) in Chicago from April 30 to May 4, 2016. Stryker re-engineered and restyled its Signature Portfolio components in collaboration

Your next operation may be performed by a machine

If you can call something that’s been on the market for 16 years a trend, then robot-assisted surgery is one of the hottest in medtech. Pioneered by Intuitive Surgical’s da Vinci abdominal surgery device, which hit the U.S. market in 2000, today almost no medical specialty lacks an entrant with a robot-assisted platform. As with

Tekcapital buys Stryker assets, mulls IPO for Bellascura subsidiary

Tekcapital (LON:TEK) said this week that it’s considering an initial public offering for the Bellascura subsidiary it formed to sell the trio of orthopedic assets it licensed from Stryker (NYSE:SYK). Oxford, England-based Tekcapital said it bought Stryker’s Slyde patient evacuation sled; the Passport trocar used with the da Vinci robot-assisted surgery system made by Intuitive Surgical (NSDQ:ISRG); and

What does Stryker want in new technologies?

“Stryker looks for two things when deciding whether to invest in a new technology,” CEO Kevin Lobo told an audience at the Cleveland Clinic Medical Innovation Summit this week. The Kalamazoo, Mich.-based company’s first criterion is whether a device meets a sizable unmet need. “If we have a market that has a huge amount of